
Safety and Feasibility of Electrochemotherapy of the Pancreas in a Porcine Model
Author(s) -
Rok Dežman,
Maja Čemažar,
Gregor Serša,
Alenka Seliškar,
Vladimira Erjavec,
Blaž Trotovšek,
Gorana Gašljević,
Maša Bošnjak,
Urša Lampreht Tratar,
Bor Kos,
Mihajlo Djokić,
Nina Milevoj,
Marina Štukelj,
Nina Boc,
Jani Izlakar,
Peter Popovič
Publication year - 2020
Publication title -
pancreas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.061
H-Index - 104
eISSN - 1536-4828
pISSN - 0885-3177
DOI - 10.1097/mpa.0000000000001642
Subject(s) - electrochemotherapy , medicine , pancreatitis , bleomycin , percutaneous , pancreatic cancer , pancreas , radiology , irreversible electroporation , ablative case , acute pancreatitis , surgery , cancer , radiation therapy , chemotherapy , electroporation , biochemistry , chemistry , gene
The use of thermal ablative therapies in the pancreatic tumors is limited because of the risk of the vessel injury and potential pancreatitis or fistula formation. Electrochemotherapy (ECT) is an ablative therapy with an established role in the treatment of cutaneous and liver tumors. This study was designed to evaluate the safety and feasibility of ECT of the pancreas in a porcine survival model.